CompletedPhase 2NCT02553265
Carbidopa for the Treatment of Excessive Blood Pressure Variability
Studying Baroreflex failure
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- Horacio C Kaufmann, MDNYU School of Medicine
- Intervention
- Carbidopa Low-Dose(drug)
- Enrollment
- 22 enrolled
- Eligibility
- 10-60 years · All sexes
- Timeline
- 2015 – 2019
Study locations (2)
- NYU Langone Medical Center, Dyautonomia Center, Suite 9Q, New York, New York, United States
- NYU Medical Center, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02553265 on ClinicalTrials.gov